State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
about
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introductionAntiretroviral pharmacology in mucosal tissuesDivergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) studyPatterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010.Conceptualisations of masculinity and self-reported medication adherence among HIV-positive Latino men in Los Angeles, California, USA.Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition.Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials.Use of a novel technology to track adherence to product use in a microbicide trial of short duration (MTN-007)Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introductionAn interdisciplinary framework for measuring and supporting adherence in HIV prevention trials of ARV-based vaginal ringsMicrobicide clinical trial adherence: insights for introductionMedication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study.Pharmacokinetics of long-acting tenofovir alafenamide (GS-7340) subdermal implant for HIV prophylaxis.A new paradigm for optimizing HIV intervention synergy: the role of interdependence in integrating HIV prevention interventionsAdherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reportingFirst-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics.Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection.Methodological lessons from clinical trials and the future of microbicide research.Breaking Down the Siloes: Developing Effective Multidisciplinary HIV Research Teams.Women and ARV-based prevention: opportunities and challenges.Measurement of Vaginal Microbicide Adherence Using Visual Inspection as Compared to Ultra Violet Light Assessment of Returned Empty Gel Applicators.Rapid measures of user's adherence to vaginal drug products using attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) and multivariate discriminant techniques.
P2860
Q26772134-02924992-1D1B-4385-B050-24C734CCB7F3Q27014675-7EE1CDC0-3736-4DE3-BB25-FE38B321B103Q27300707-B6C2B2B4-78DD-48E2-B28F-C4A003395362Q27313352-42EA47CC-9C59-45EE-AEA5-B96198892E3BQ27318158-085D4B3B-078F-42DF-B952-B0BA3089DD80Q33769408-5E0E423F-1C63-406B-9C48-D1DBFF34325CQ33934337-18FF4C70-A2C2-46FB-9F51-D60413FA298EQ33978803-F242FE62-835D-410D-9E5D-848540DB98EFQ34034381-95C12929-FB2A-4B38-A08A-C947BD601638Q34149653-4D6E3357-7234-4921-9939-7D413BF9ADB3Q34180615-C07E5AB3-E9C4-42D9-B3CD-129EC652501AQ34180621-057F9F78-A4BB-401D-AC71-69EAE687522DQ34180658-20D85123-C20D-4AA8-8FB8-C3CC97532951Q34337475-A1D269B4-121B-46F0-AD52-267B5374B292Q34606560-6EF5389B-9A82-4DEA-81E3-FC6F05873287Q34696493-B03D420F-368B-41B8-86C6-AD3E1513E18AQ35558214-8C5014B8-1875-4791-92A9-E94D8DEF9FCEQ35746114-D867C2DC-E09D-47A2-AF41-FABBEB48FAE0Q36865202-DBC31AFD-1F68-4B56-B667-04880183263AQ36902453-ADC3E941-E778-4C71-B418-9A529BAD37E8Q37216377-13E89E54-9630-473F-8433-26EC13C2EB2EQ37265920-8F0688C4-9ECC-4371-904F-73E335C157F5Q37520083-4549074C-478E-49EF-A586-B94AAD9315FCQ37626085-57FBE734-7A4C-48BC-AD5A-2F76F14CA270Q38062882-3835E3A6-B089-4386-92BE-1A20AC9F14A0Q40607540-43F74E95-9BD8-4472-BEFD-A5F81ABBB463Q46553256-2350994D-1600-44A7-9311-ACE52B09A1E0Q46661298-B203C129-5505-4309-AAA9-DC342AFB708BQ55005002-2FBB0D2F-9483-49A1-90B7-81AE66695260
P2860
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@ast
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@en
type
label
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@ast
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@en
prefLabel
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@ast
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@en
P2093
P2860
P1476
State of the science of adherence in pre-exposure prophylaxis and microbicide trials.
@en
P2093
Felix M Muchomba
Nabila El-Bassel
Robin E Gearing
P2860
P304
P356
10.1097/QAI.0B013E31826F9962
P407
P577
2012-12-01T00:00:00Z